Physician profile
Daniel J Newton
NPI 1649387507
$1,006.76
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $43.72 · 2021: $159 · 2022: $231 · 2023: $282 · 2024: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $395 · Education: $18.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $395.35 |
| Education | $18.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $193.03 | 2022-2023 | Euphora, Onyx Frontier, Endurant Iis |
| Abbott Laboratories | $170.16 | 2021-2023 | Xience Skypoint, Pressurewire |
| Cook Medical LLC | $144.07 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $68.03 | 2020-2024 | Lifevest |
| Janssen Pharmaceuticals, INC | $60.17 | 2020-2021 | |
| Inari Medical, INC. | $52.49 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $48.84 | 2022-2023 | Wolverine Coronary Cutting Balloon |
| Lantheus Medical Imaging, INC. | $44.40 | 2021-2023 | Definity |
| Atricure, INC. | $35.07 | 2023 | |
| Novartis Pharmaceuticals Corporation | $33.14 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $26.77 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $23.35 | 2024 | Farxiga |
| Silk Road Medical, INC. | $21.23 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Biotronik INC. | $18.30 | 2022 | |
| Merck Sharp & Dohme LLC | $18.09 | 2024 | Winrevair |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $17.93 | 2021 | |
| Cardinal Health 200 LLC | $16.48 | 2020 | |
| Ekos Corporation | $15.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Newton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.